Valdezamo, John Ivan P.
HRN: 21-21-17 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2025
CEFUROXIME 1.5GM (VIAL)
06/11/2025
06/18/2025
500MG
IV
Q8
T/C Liver Pathology
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes